skip to navigation skip to content
search
  • About us
    • Who we are
    • Horizon scanning
    • Public involvement
      • Public Involvement Network Advisory Group
      • Patient group partners
      • Public partners
    • Policies & publications
    • Minutes
    • Meetings
    • Register for a meeting
    • ILAP
    • Latest update
      • HIS website survey
      • Speeding up access to new medicines in Scotland: abbreviated process
      • International Collaboration
      • Joint statement: NICE and SMC/HIS collaboration
      • NICE draft recommendations published on the use of treatments for COVID-19
      • Healthcare Improvement Scotland
      • NICE and SMC/HIS collaboration on health technology appraisal of therapeutics for COVID-19
      • Her Majesty Queen Elizabeth II
      • April 2022 decisions news release
      • New access tool launched as part of SMC’s joint work on streamlining patient access to innovative medicines
      • December 2021 decisions news release
      • November 2021 decisions news release
      • March 2023 decisions news release
      • SMC publishes a Collaborative Advice Document for treatments for COVID-19
      • Public Partner Advert
      • Fast Track Resubmission Process
      • NICE issues final draft guidance for nirmatrelvir plus ritonavir for treating COVID-19 (partial review of TA878)
    • Contact us
  • Medicines advice
  • How we decide
    • PACE
    • Interim acceptance decision option
    • Ultra-orphan medicines for extremely rare conditions
    • Abbreviated submissions
  • Making a submission
Homepage Purple Pills Banner

Advising on new medicines for Scotland

This month's advice

We are the national source of advice on the clinical and cost-effectiveness of all new medicines for NHSScotland. Our aim is to ensure that people in Scotland have timely access to medicines that provide most benefit based on best available evidence.

Nurse checking details on a computer

Medicines advice

Find out what our committee has advised on a medicine.

Find out more
Meeting agenda with meeting in background

How we make our decisions

We carefully consider evidence from pharmaceutical companies, patient groups and clinicians to help us make our decisions. 

Find out more
Man filling in a form

Making a submission

Companies can submit a medicine to us for consideration. Patient groups can submit evidence to help our committee make a decision on a medicine.

Find out how

Public involvement

The views of patient groups and the public are key to what we do. Find out more about how we work with patient groups and the public – and how to get involved.

Find out more
Crowd of people in street, commuters

Medicines under consideration

Find out what medicines we’ll be assessing over the next few months.

Medicines under consideration
Pills image

Register for a meeting

All our SMC Committee meetings are held in public. Find out more and register your interest in attending.

Register

Sign up to our email notifications

Our monthly email helps keep you up to date with what SMC is doing and includes all our latest decisions, straight to your inbox.

Sign up
  • Contact us
  • Register for a meeting
  • Newsletter sign up
  • Accessibility
  • Terms and conditions
  • Respecting your privacy
  • Freedom of information

© Scottish Medicines Consortium

  • NHS Scotland Logo